Navidea Biopharmaceuticals Debt to Equity Ratio 2006-2019 | NAVB

Current and historical debt to equity ratio values for Navidea Biopharmaceuticals (NAVB) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Navidea Biopharmaceuticals debt/equity for the three months ending June 30, 2019 was 0.21.
Navidea Biopharmaceuticals Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-06-30 $0.00B $0.00B 0.21
2019-03-31 $0.00B $0.00B 7.24
2018-12-31 $0.00B $0.00B 0.00
2018-09-30 $0.00B $0.00B 0.00
2018-06-30 $0.00B $0.00B 0.00
2018-03-31 $0.00B $0.01B 0.00
2017-12-31 $0.00B $0.01B 0.00
2017-09-30 $0.00B $0.02B 0.00
2017-06-30 $0.00B $0.02B 0.00
2017-03-31 $0.00B $0.02B 0.00
2016-12-31 $0.01B $-0.07B -0.14
2016-09-30 $0.01B $-0.06B -0.17
2016-06-30 $0.01B $-0.06B -0.15
2016-03-31 $0.01B $-0.06B -0.19
2015-12-31 $0.06B $-0.05B -1.13
2015-09-30 $0.06B $-0.43B -0.14
2015-06-30 $0.06B $-0.05B -1.32
2015-03-31 $0.03B $-0.04B -0.83
2014-12-31 $0.03B $-0.03B -0.99
2014-09-30 $0.03B $-0.03B -0.95
2014-06-30 $0.00B $-0.02B 0.00
2014-03-31 $0.03B $-0.02B -2.12
2013-12-31 $0.02B $-0.00B -5.88
2013-09-30 $0.03B $0.01B 2.94
2013-06-30 $0.03B $-0.00B -14.86
2013-03-31 $0.01B $-0.00B -3.77
2012-12-31 $0.01B $-0.00B -4.93
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.01B 0.43
2012-03-31 $0.00B $0.02B 0.00
2011-12-31 $0.01B $0.02B 0.31
2011-09-30 $0.00B $0.03B 0.00
2011-06-30 $0.00B $0.01B 0.00
2011-03-31 $0.00B $0.01B 0.00
2010-12-31 $0.00B $0.00B 0.00
2010-09-30 $0.00B $0.00B 0.01
2010-06-30 $0.00B $0.00B 0.01
2010-03-31 $0.00B $-0.01B -0.09
2009-12-31 $0.00B $-0.01B 0.00
2009-09-30 $0.00B $-0.01B -0.09
2009-06-30 $0.00B $-0.03B -0.03
2009-03-31 $0.00B $-0.02B -0.06
2008-12-31 $0.00B $-0.00B -0.31
2008-09-30 $0.00B $-0.00B -0.54
2008-06-30 $0.00B $0.00B -8.83
2008-03-31 $0.00B $-0.00B -0.49
2007-12-31 $0.00B $-0.00B -0.23
2007-09-30 $0.00B $-0.00B -0.05
2007-06-30 $0.00B $-0.00B -0.05
2007-03-31 $0.00B $-0.00B -0.07
2006-12-31 $0.00B $0.00B -0.33
2006-09-30 $0.00B $0.00B 0.13
2006-06-30 $0.00B $0.00B 0.04
2006-03-31 $0.00B $0.00B 0.03
2005-12-31 $0.00B $0.00B 0.03
2005-09-30 $0.00B $0.01B 0.02
2005-06-30 $0.00B $0.01B 0.02
2005-03-31 $0.00B $0.01B 0.01
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.005B $0.001B
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $109.454B 23.32
Intuitive Surgical (ISRG) United States $57.612B 50.39
Edwards Lifesciences (EW) United States $44.757B 43.56
IDEXX Laboratories (IDXX) United States $23.509B 58.98
Fresenius Medical Care AG KGaA (FMS) Germany $19.957B 13.22
Teleflex (TFX) United States $17.035B 36.16
Olympus (OCPNY) Japan $16.189B 121.13
SONOVA HOLDING (SONVY) Switzerland $14.665B 0.00
DexCom (DXCM) United States $14.456B 214.23
Hologic (HOLX) United States $13.317B 21.02
STERIS (STE) Ireland $12.870B 29.68
Sysmex ADR (SSMXY) Japan $12.420B 33.48
Varian Medical Systems (VAR) United States $9.773B 23.38
ABIOMED (ABMD) United States $8.715B 49.89
Masimo (MASI) United States $7.964B 48.32
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.135B 22.91
Penumbra (PEN) United States $5.054B 181.56
Elekta AB (EKTAY) Sweden $4.932B 39.35
Globus Medical (GMED) United States $4.827B 30.64
LivaNova (LIVN) United Kingdom $3.751B 28.60
Cantel Medical (CMD) United States $3.706B 37.59
Tandem Diabetes Care (TNDM) United States $3.350B 0.00
Wright Medical Group (WMGI) Netherlands $2.662B 233.44
Nihon Kohden (NHNKY) Japan $2.529B 25.45
Nevro (NVRO) United States $2.495B 0.00
Integer Holdings (ITGR) United States $2.473B 17.49
Glaukos (GKOS) United States $2.210B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.724B 31.97
Silk Road Medical (SILK) United States $1.230B 0.00
Veracyte (VCYT) United States $1.205B 0.00
OPKO Health (OPK) United States $1.170B 0.00
Natus Medical (NTUS) United States $1.031B 24.02
Accelerate Diagnostics (AXDX) United States $0.977B 0.00
CryoLife (CRY) United States $0.974B 92.79
ORTHOFIX MEDICAL INC (OFIX) United States $0.952B 29.89
Inogen (INGN) United States $0.940B 23.05
Tactile Systems Technology (TCMD) United States $0.924B 114.19
Luminex (LMNX) United States $0.921B 0.00
Corindus Vascular Robotics (CVRS) United States $0.889B 0.00
Pacific Biosciences Of California (PACB) United States $0.857B 0.00
Mesa Laboratories (MLAB) United States $0.852B 39.38
Quotient (QTNT) Switzerland $0.714B 0.00
AngioDynamics (ANGO) United States $0.699B 22.87
AxoGen (AXGN) United States $0.573B 0.00
Intersect ENT (XENT) United States $0.503B 0.00
OrthoPediatrics (KIDS) United States $0.464B 0.00
Si-Bone (SIBN) United States $0.457B 0.00
Fluidigm (FLDM) United States $0.443B 0.00
ViewRay (VRAY) United States $0.387B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.372B 14.29
GenMark Diagnostics (GNMK) United States $0.369B 0.00
Alphatec Holdings (ATEC) United States $0.343B 0.00
Sientra (SIEN) United States $0.316B 0.00
Semler Scientific (SMLR) United States $0.312B 52.75
Accuray (ARAY) United States $0.269B 0.00
IRadimed (IRMD) United States $0.239B 39.62
CRH Medical (CRHM) Canada $0.234B 81.25
RTI Surgical (RTIX) United States $0.222B 33.33
TransEnterix (TRXC) United States $0.207B 0.00
SeaSpine Holdings (SPNE) United States $0.204B 0.00
Neuronetics (STIM) United States $0.178B 0.00
Stereotaxis (STXS) United States $0.167B 0.00
ConforMIS (CFMS) United States $0.126B 0.00
Sensus Healthcare (SRTS) United States $0.104B 0.00
Second Sight Medical Products (EYES) United States $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Ekso Bionics Holdings (EKSO) United States $0.063B 0.00
Spectral Diagnostics (EDTXF) Canada $0.062B 0.00
Helius Medical Technologies (HSDT) United States $0.052B 0.00
Vermillion (VRML) United States $0.052B 0.00
Electromed (ELMD) United States $0.044B 22.83
Xtant Medical Holdings (XTNT) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.036B 0.00
Nuvectra (NVTR) United States $0.028B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.027B 0.00
Restoration Robotics (HAIR) United States $0.026B 0.00
Ra Medical Systems (RMED) United States $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.025B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Bioanalytical Systems (BASI) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
Lianluo Smart (LLIT) China $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.83
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Dynatronics (DYNT) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00